SBI Okasan Asset Management’s Amgen AMGN Stock Holding History

SBI Okasan Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-650	Closed	-$227K	–	323
2026 Q1	$227K	Sell	650 -3	-0.5%	-$1.07K	0.01%	239
2025 Q4	$215K	Buy	+653	New	+$207K	0.01%	243

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SBI Okasan Asset Management's AMGN Position: Q2 2026 in Review

SBI Okasan Asset Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 650 shares — an estimated $227K sold.

SBI Okasan Asset Management first reported a position in AMGN in Q4 2025 and held it in 2 quarters. The position peaked at $227K in Q1 2026. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

SBI Okasan Asset Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
SBI Okasan Asset Management sold 650 Amgen shares in Q2 2026, an estimated $227K.
SBI Okasan Asset Management first reported a position in Amgen in Q4 2025 and held it in 2 quarters.
SBI Okasan Asset Management's Amgen position peaked at $227K in Q1 2026.
3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.